| 1º - Comunicação | 2026-04-04 | 40 | 0 |
| 2º - NCLEX CRUSADE ACADEMY TEST - 2 GENERAL DIAGNOSTICS TEST I | 2026-04-04 | 25 | 1 |
| 3º - NCLEX CRUSADE ACADEMY TEST - 1 SKILLS AND PROCEDURES | 2026-04-04 | 30 | 0 |
| 4º - NCLEX CRUSADE ACADEMY TEST - 21 TYPES OF DEPRESSIVE DISORDERS | 2026-04-04 | 10 | 0 |
| 5º - NCLEX CRUSADE ACADEMY TEST - 20 EATING DISORDERS | 2026-04-04 | 20 | 0 |
| 6º - NCLEX CRUSADE ACADEMY TEST - 19 POSTPARTUM MENTAL DISORDERS | 2026-04-04 | 10 | 0 |
| 7º - NCLEX CRUSADE ACADEMY TEST - 18 MOOD DISORDERS - LITHIUM TOXICITY | 2026-04-04 | 15 | 1 |
| 8º - AVI 1 | 2026-04-04 | 9 | 0 |
| 9º - NCLEX CRUSADE ACADEMY TEST - 17 SUICIDAL BEHAVIOR | 2026-04-04 | 20 | 0 |
| 10º - DIDATTICA E PEDAGOGIA INTERCULTURALE | 2026-04-03 | 74 | 0 |
| 11º - sociologia dell'educazione | 2026-04-03 | 69 | 0 |
| 12º - Lingua e Trad Francese 4 | 2026-04-03 | 33 | 0 |
| 13º - Reti azienda 12 | 2026-04-03 | 10 | 1 |
| 14º - Metrologia | 2026-04-03 | 211 | 2 |
| 15º - NCLEX CRUSADE ACADEMY TEST - 16 HYPERACTIVITY DISORDER - DEMENTIA - ALZHEIMER'S | 2026-04-03 | 25 | 0 |
| 16º - NCLEX CRUSADE ACADEMY TEST - 15 SCHIZOPHRENIA- ANTIPSYCHOTIC MEDICATIONS - INTER | 2026-04-03 | 20 | 0 |
| 17º - NCLEX CRUSADE ACADEMY TEST -14 AGGRESSIVE BEHAVIOR | 2026-04-03 | 20 | 0 |
| 18º - NCLEX CRUSADE ACADEMY TEST - 13 BIPOLAR DISORDER | 2026-04-03 | 30 | 0 |
| 19º - NCLEX CRUSADE ACADEMY TEST - 12 AXIETY + PANIC ATTACK CRISIS INTERVENTION + PTSD | 2026-04-03 | 30 | 0 |
| 20º - NCLEX CRUSADE ACADEMY TEST - 11 TREATMENT MODALITIES FOR MENTAL ILLNESS + COPING | 2026-04-03 | 30 | 0 |
| 21º - NCLEX CRUSADE ACADEMY TEST - 10 SUICIDE BEHAVIOR | 2026-04-03 | 25 | 0 |
| 22º - NCLEX CRUSADE ACADEMY TEST - 9 CRISIS INTERVENTION | 2026-04-03 | 25 | 0 |
| 23º - Змістовний модуль 11. Тема 2. ЛФО імунної системи у дітей. Клініко-лаоора гарні | 2026-04-03 | 20 | 0 |
| 24º - NCLEX CRUSADE ACADEMY TEST - 8 ABUSE AND NEGLECT | 2026-04-03 | 25 | 0 |
| 25º - Змістовний модуль 11. Тема 1. Ембріогенез кровотворної системи та АФО системи кр | 2026-04-03 | 20 | 0 |
SHOW MORE |
